
Francesca Khani, MD
577 posts

Francesca Khani, MD
@FKhaniPath
Associate Professor of Pathology, Weill Cornell Medicine. Specializing in Urologic pathology. #gupath Opinions/views are my own.



1/2 Just published in @JAMAOnc: 15-year outcomes of Active Monitoring, Surgery, and Radiotherapy for cribriform-positive and cribriform-negative prostate cancer in the ProtecT trial. Secondary analysis based on centralised biopsy review🔬 Article: jamanetwork.com/journals/jamao…









Thanks again to the wonderful panel @Williamson_SR @FKhaniPath @BehfarEhdaieMD and moderators @FionaMacPath @LotanLab for yesterday’s @GU_Path_Society Companion Society Meeting #USCAP2024 - synthesized knowledge & fresh thinking 💭 made it a success!

Another commentary on reasons for not renaming 3+3 as "not cancer" - this from Dr Samaratunga et al. Hits on several important points #gupath sciencedirect.com/science/articl…




#PathTwitter #gupath folks - in the following scenario: - intraductal proliferation (basal cell marker #IHC +) - dense cribriform architecture - background HG #prostatecancer (GS459/GrdGrp 5) 2 questions: polls in Tweets/posts below 👇🏻👇🏻👇🏻



🗞️@Forbes Published today! Are we on the verge of a new drug combo for colorectal cancer? Read more about our work on this immunotherapy called the BOT (Botensilimab). We describe this “inside-out”🌊 wave of regression by immune cells. @TheAlexKnapp forbes.com/sites/alexknap…


We (@nygenome cancer compbio group) are very fortunate to work closely with @WCMEnglanderIPM and have several papers in preparation. Here is one focused on brain metastases in prostate cancer with @FKhaniPath @willbfx @mishabeltran nature.com/articles/s4169…











